Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Sanofi (SNY) Net Margin (2016 - 2025)

Historic Net Margin for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to 33.4%.

  • Sanofi's Net Margin rose 361700.0% to 33.4% in Q4 2025 from the same period last year, while for Dec 2025 it was 5.39%, marking a year-over-year increase of 52100.0%. This contributed to the annual value of 17.91% for FY2025, which is 43700.0% up from last year.
  • Latest data reveals that Sanofi reported Net Margin of 33.4% as of Q4 2025, which was up 361700.0% from 8.85% recorded in Q3 2025.
  • In the past 5 years, Sanofi's Net Margin registered a high of 111.94% during Q4 2022, and its lowest value of 2.77% during Q4 2024.
  • Moreover, its 5-year median value for Net Margin was 19.26% (2021), whereas its average is 20.98%.
  • As far as peak fluctuations go, Sanofi's Net Margin skyrocketed by 1094100bps in 2022, and later tumbled by -1129600bps in 2023.
  • Sanofi's Net Margin (Quarter) stood at 2.54% in 2021, then skyrocketed by 4315bps to 111.94% in 2022, then plummeted by -101bps to 1.02% in 2023, then tumbled by -171bps to 2.77% in 2024, then skyrocketed by 1307bps to 33.4% in 2025.
  • Its Net Margin stands at 33.4% for Q4 2025, versus 8.85% for Q3 2025 and 13.82% for Q2 2025.